Humana backs FY23 adjusted EPS view to ‘at least’ $28.25, consensus $28.29

Raises 2023 individual Medicare Advantage membership growth by 50,000 to ‘approximately 825,000’, or 18% growth over FY 2022 ending membership, meaningfully higher than industry growth. Highlights stabilizing Medicare Advantage utilization environment based on most recent claims activity; affirms FY 2023 Insurance segment benefit expense ratio guidance range of 86.3% to 87.3%.